DexCom, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2521311074
USD
66.84
0.9 (1.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
1,259.60
1,209.30
1,157.10
1,036.00
1,113.50
994.20
1,004.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,259.60
1,209.30
1,157.10
1,036.00
1,113.50
994.20
1,004.30
Raw Material Cost
466.90
461.90
468.30
447.00
457.70
400.40
377.60
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.20
4.70
4.70
4.70
4.90
4.70
4.80
Selling and Distribution Expenses
321.50
331.40
328.00
310.10
327.40
306.40
332.70
Other Expenses
14.40
15.28
14.35
14.05
13.46
13.07
13.12
Total Expenditure (Excl Depreciation)
936.60
950.80
944.50
902.30
924.60
842.20
846.30
Operating Profit (PBDIT) excl Other Income
323
258.5
212.60000000000002
133.7
188.9
152
158
Other Income
21.90
114.50
33.20
25.30
27.30
30.10
34.60
Operating Profit (PBDIT)
410.10
420.60
308.80
219.00
274.00
237.40
244.70
Interest
4.20
4.70
4.70
4.70
4.90
4.70
4.80
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
792.70
747.40
688.80
589.00
655.80
593.80
626.70
Depreciation
65.20
63.60
63.00
60.00
57.80
55.30
52.10
Profit Before Tax
340.70
352.30
241.10
154.30
211.30
177.40
187.80
Tax
73.40
68.50
61.30
48.90
59.60
42.80
44.30
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
267.30
283.80
179.80
105.40
151.70
134.60
143.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
267.30
283.80
179.80
105.40
151.70
134.60
143.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
267.30
283.80
179.80
105.40
151.70
134.60
143.50
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,746.00
2,726.10
2,573.10
2,266.60
2,102.60
1,979.00
2,434.30
Earnings per share (EPS)
0.68
0.7
0.45
0.27
0.38
0.34
0.35
Diluted Earnings per share
0.68
0.7
0.45
0.27
0.38
0.34
0.35
Operating Profit Margin (Excl OI)
25.64%
20.05%
18.37%
12.91%
16.96%
15.29%
15.73%
Gross Profit Margin
32.22%
34.39%
26.28%
20.69%
24.17%
23.41%
23.89%
PAT Margin
21.22%
23.47%
15.54%
10.17%
13.62%
13.54%
14.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 13.12% vs 7.64% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 76.20% vs -40.81% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 57.36% vs -8.43% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is -14.29% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of DexCom, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,259.60
1,569.60
-310.00
-19.75%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,259.60
1,569.60
-310.00
-19.75%
Raw Material Cost
466.90
335.80
131.10
39.04%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.20
0.00
4.20
Selling and Distribution Expenses
321.50
602.90
-281.40
-46.67%
Other Expenses
14.40
26.77
-12.37
-46.21%
Total Expenditure (Excl Depreciation)
936.60
1,206.40
-269.80
-22.36%
Operating Profit (PBDIT) excl Other Income
323.00
363.20
-40.20
-11.07%
Other Income
21.90
21.80
0.10
0.46%
Operating Profit (PBDIT)
410.10
442.00
-31.90
-7.22%
Interest
4.20
0.00
4.20
Exceptional Items
0.00
-308.90
308.90
100.00%
Gross Profit (PBDT)
792.70
1,233.80
-441.10
-35.75%
Depreciation
65.20
42.70
22.50
52.69%
Profit Before Tax
340.70
90.40
250.30
276.88%
Tax
73.40
26.20
47.20
180.15%
Provisions and contingencies
0
0
0.00
Profit After Tax
267.30
64.20
203.10
316.36%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
267.30
64.20
203.10
316.36%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
267.30
64.20
203.10
316.36%
Equity Capital
0
0
0.00
Face Value
0.00
1.00
0.00
Reserves
2,746.00
10,337.60
-7,591.60
-73.44%
Earnings per share (EPS)
0.68
0.11
0.57
518.18%
Diluted Earnings per share
0.68
0.11
0.57
518.18%
Operating Profit Margin (Excl OI)
25.64%
24.05%
0.00
1.59%
Gross Profit Margin
32.22%
8.48%
0.00
23.74%
PAT Margin
21.22%
4.09%
0.00
17.13%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 125.96 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 4.16% vs 4.51% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 13.12% vs 7.64% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 26.73 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -5.81% vs 57.84% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 76.20% vs -40.81% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 38.82 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 26.82% vs 11.07% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 57.36% vs -8.43% in Dec 2024

Quarterly - Interest
Interest 0.42 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -10.64% vs 0.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -14.29% vs 0.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.64%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024